October 11, 2024

Merck and Astellas/Pfizer’s bladder cancer combination receives MHRA approval – PMLiVE

October 11, 2024

Cisplatin’s Prevalence in Bladder Cancer Falters With the Introduction of Enfortumab Vedotin – OncLive

October 11, 2024

VisualAbstract: Extended Lymphadenectomy is Not Associated with Improved Survival in Muscle-Invasive Bladder Cancer – 2 Minute Medicine

October 10, 2024

Extended lymphadenectomy does not improve survival in muscle-invasive bladder cancer – 2 Minute Medicine

October 10, 2024

Antiviral Enzymes Implicated in Bladder Cancer – Inside Precision Medicine